A 68-year-old woman with severe treatment-resistant depression is scheduled to begin a course of ECT three times weekly. Her current medications include lithium 600 mg twice daily, escitalopram 20 mg daily, and lorazepam 1 mg at bedtime for insomnia. Her treatment team is reviewing which medications require adjustment during the ECT course. What is the most appropriate medication management strategy?